Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 9:59 AM UTC
| NCT Number | NCT03854110 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE1 |
| Target Enrollment | 80 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Persevere Therapeutics Inc. |
| Last Updated on CT.gov | July 23, 2026 (Jul 23, 2026) |
As of August 31, 2026: Clinical trial NCT03854110 is currently recruiting participants. This phase1 study for ovarian cancer is actively seeking new participants at 4 locations across the United States. The study is sponsored by Persevere Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03854110 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03854110 was last updated Jul 23, 2026 (July 23, 2026). HelloStudys verifies this status automatically.